Sarcoma  >>  Pemazyre (pemigatinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pemazyre (pemigatinib) / Incyte
PERELI, NCT06389799: A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma

Not yet recruiting
2
33
Europe
Pemigatinib, Retifanlimab
Lund University Hospital
Dedifferentiated Liposarcoma
12/27
12/28

Download Options